ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 120 filers reported holding ARCELLX INC in Q1 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,571,000 | +22.0% | 1,075,000 | +7.5% | 2.85% | +16.7% |
| Q2 2023 | $31,620,000 | -16.2% | 1,000,000 | -18.4% | 2.44% | -1.9% |
| Q1 2023 | $37,742,250 | -17.9% | 1,225,000 | -17.5% | 2.49% | -13.2% |
| Q4 2022 | $45,974,940 | -23.3% | 1,484,020 | -53.5% | 2.87% | +0.5% |
| Q3 2022 | $59,912,000 | -17.5% | 3,191,878 | -20.5% | 2.86% | -20.1% |
| Q2 2022 | $72,625,000 | +29.0% | 4,016,878 | 0.0% | 3.58% | +20.4% |
| Q1 2022 | $56,317,000 | – | 4,016,878 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
| NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
| Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
| Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
| Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
| Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
| Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
| Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
| Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |